Access to gene therapy for rare diseases when commercialization is not fit for purpose.
Thomas Andrew FoxJuan Antonio BuerenFabio CandottiAlain FischerAlessandro AiutiArjan Lankesternull nullClaire BoothPublished in: Nature medicine (2023)
Keyphrases